Late-onset gastrointestinal pain in juvenile dermatomyositis as a manifestation of ischemic ulceration from chronic endarteropathy.код для вставкиСкачать
Arthritis & Rheumatism (Arthritis Care & Research) Vol. 57, No. 5, June 15, 2007, pp 881– 884 DOI 10.1002/art.22782 © 2007, American College of Rheumatology CASE REPORT Late-Onset Gastrointestinal Pain in Juvenile Dermatomyositis as a Manifestation of Ischemic Ulceration From Chronic Endarteropathy GULNARA MAMYROVA,1 DAVID E. KLEINER,2 LAURA JAMES-NEWTON,1 BRACHA SHAHAM,3 FREDERICK W. MILLER,1 AND LISA G. RIDER1 Introduction Case 1 Juvenile dermatomyositis (DM) is a chronic inﬂammatory disease characterized by proximal muscle weakness and rash. Other organ systems, including the gastrointestinal tract, are frequently involved. Gastrointestinal manifestations of juvenile DM include dysphagia, bowel dysmotility, and vasculitis with associated malabsorption (1). Gastrointestinal ulceration is thought to be characteristic of the vasculopathy associated with juvenile-onset DM, rather than adult-onset DM, and might uncommonly lead to intestinal perforation (2). An autopsy series of patients with juvenile DM from the 1960s, prior to the optimal use of corticosteroids and other immunosuppressive agents, demonstrated frequent ulceration, perforation, and vascular changes in the bowels of patients with juvenile DM (3). We report 2 patients with severe gastrointestinal ulceration that resulted in surgery, and we review the pathologic ﬁndings and risk factors for the development of these serious, often life-threatening manifestations of juvenile DM. The patient, a girl age 14.6 years presented with muscle pain, fatigue, and difﬁculty walking, followed by difﬁculty raising her arms above her head and heliotrope rash. She had been diagnosed with juvenile DM at age 11. Serum creatine kinase (CK) was elevated at 11,734 units/liter (normal range 0 –252 units/liter). Muscle biopsy demonstrated scattered perivascular lymphocytes with a normal capillary bed and no evidence of infarction. Initial treatment of her juvenile DM consisted of daily oral prednisone, but monthly intravenous immunoglobulin (IVIG) was added due to lack of response. The patient’s juvenile DM improved, but 2 ﬂares had occurred with reduction of prednisone dose, therefore azathioprine was started. Four months after diagnosis, the patient developed 2 episodes of intermittent sharp abdominal pain in the right upper quadrant with nausea and bilious emesis. This episodic pain was associated with bloating. Stool was negative for occult blood. Metronidazole relieved her symptoms; however, they recurred upon discontinuation. Differential diagnosis included corticosteroid-induced ulceration, gastritis, or abdominal pain associated with small bowel overgrowth. Esophagogastroduodenoscopy revealed a shallow ulceration at the gastroesophageal junction and mild esophagitis. Multiple medications, including ranitidine, lansoprazole, dicyclomine, and hyoscyamine sulfate, provided no relief of her symptoms. The patient’s juvenile DM remained active, with mild but improving weakness, as well as with persistent Gottron’s papules and periungual erythema. Sixteen months after diagnosis, the abdominal pain worsened and became continuous, and she developed low-grade fever and vomiting. One month later, the patient presented with an acute abdomen with severe diffuse periumbilical and right lower quadrant abdominal pain. There was marked percussion tenderness on examination. Flat and upright ﬁlms of the abdomen revealed no signs of obstruction or evidence of free air. The patient underwent an exploratory laparotomy with hemicolectomy and ileostomy. The colon was remarkable for hyperemia and areas of ulceration, with minimal inﬂammation in the submucosa, abnormally dilated Supported in part by the intramural research programs of the NIH, the National Institute of Environmental Health Sciences, and the National Cancer Institute. Dr. Mamyrova is a research fellow of the Cure JM Foundation and previously received support from the Myositis Association. 1 Gulnara Mamyrova, MD, PhD, Laura James-Newton, PhD, RN, Frederick W. Miller, MD, PhD, Lisa G. Rider, MD: Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, Bethesda, Maryland; 2 David E. Kleiner, MD: National Cancer Institute, National Institutes of Health, Bethesda, Maryland; 3Bracha Shaham, MD: University of Southern California School of Medicine, Children’s Hospital, Los Angeles, California. Address correspondence to Lisa G. Rider, MD, Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, NIH, CRC Room 4-2332, MSC 1301, 10 Center Drive, Bethesda, MD 20892-1301. E-mail: riderl@ mail.nih.gov. Submitted for publication August 4, 2006; accepted in revised form October 25, 2006. 881 882 Figure 1. Vascular changes present in the intestine of patient 1, with gastrointestinal ulceration and juvenile dermatomyositis. A, Chronic ulceration with sclerosis of the submucosa. Although there was a ﬁbrinopurulent exudate in the ulcer bed, there is minimal chronic inﬂammation in the exposed submucosa and essentially no granulation tissue (hematoxylin and eosin stained; original magniﬁcation ⫻ 20). B, A single occluded artery was seen in the adventitia of this patient’s bowel resection. The lumen shows concentric narrowing by a ﬁbromyxoid neointima (hematoxylin and eosin stained; original magniﬁcation ⫻ 40). vessels in the lamina propria and submucosa, and a single occluded vessel (Figure 1). One month after surgery, von Willebrand factor VIII– related antigen was elevated to 270% (normal 80 –130%). The patient continued taking daily oral prednisone and azathioprine, as well as monthly IVIG. Four months later, the ileostomy was closed. Almost 2 years after surgery, the patient’s juvenile DM was inactive. Case 2 The second patient, a girl age 13.3 years with a history of type 1 diabetes mellitus and a diagnosis of juvenile DM at age 11, presented with reported difﬁculty skiing, muscle pain, and fatigue. Three months later, she developed malar rash and linear extensor erythema, as well as heliotrope and V-sign rashes. Her weakness progressed, with an inability to dress or get out of bed. Initial serum CK was 1,228 units/liter, lactate dehydrogenase was 704 units/ Mamyrova et al liter, and aldolase was 10.4 units/liter. Initial treatment consisted of weekly intramuscular methotrexate (MTX); daily oral prednisone was started 1 month later with a rapid response. Twenty-two months after diagnosis, the patient discontinued her MTX when her illness was almost in remission. One month later, her disease relapsed with weakness, rash, dysphonia, and increased serum CK levels of 4,642 units/liter and aldolase of 25.3 units/liter. Prednisone was increased to 60 mg/day, weekly MTX was restarted, and the patient received 3 doses of intravenous methylprednisolone (30 mg/kg/day). Her weakness progressed, however, and she became bed bound; she also developed dysphagia and sinus tachycardia. Daily intravenous methylprednisolone and cyclosporine were added. Her symptoms improved, but 2 weeks later she developed intermittent abdominal pain and constipation. Within 5 days, the pain became severe. Examination revealed tenderness in the left lower quadrant and absent bowel sounds. Abdominal computed tomography (CT) was normal, but a second scan 4 days later showed pneumoperitoneum with ﬂuid adjacent to the duodenum, suggestive of a duodenal perforation. Laparotomy revealed extensive fecal soilage of the abdominal cavity with a full-thickness perforation of the third portion of the duodenum. Postoperatively, the patient gradually improved with increased methylprednisolone and initiation of IVIG. One week following surgery, the abdominal pain recurred and progressively worsened. Abdominal CT showed multiple perforations of the small and large intestine. Repeat laparotomy demonstrated free air and extensive purulent exudates throughout the abdominal cavity. Multiple spontaneous perforations were present in the transverse and sigmoid colon. Surgical treatment included repair of the perforations, transverse colectomy, and creation of a colostomy. Pathology of the resected bowel showed ﬁbrinous peritonitis and mucosal edema without evidence of mucosal ulceration. Perforation of the bowel was not apparent in sections made available for our review. Vascular changes included narrowing or complete occlusion of multiple small and medium arteries, with subintimal foamy cells, ﬁbrinoid degeneration, and signiﬁcant luminal compromise, along with localized clusters of dilated veins (Figure 2). Immunophenotyping showed T cells surrounding the vessel, but not within the vessel wall, and inﬁltration of macrophages through the muscularis into the intima. Most of the foam cells stained with smooth muscle actin, suggestive of a myoﬁbroblast phenotype. Cyclophosphamide 10 mg/kg intravenously and IVIG 2 gm/kg twice monthly were started postoperatively. The patient gradually improved; she had no further abdominal pain and her strength improved, but remained mildly impaired. One year after surgery, her muscle enzyme levels were normal and von Willebrand factor VIII–related antigen remains elevated at 188%. Discussion We present the clinical and pathologic features of 2 patients with juvenile DM with severe gastrointestinal ulceration or perforation who required surgery. As these cases demonstrate, abdominal pain may occur at any time dur- Ischemic Ulceration in Juvenile DM 883 Figure 2. Vascular changes present in the intestine of patient 2, with bowel perforations and juvenile dermatomyositis. A, Multiple small arteries showed narrowing or complete occlusion, with a representative artery shown here. These occlusive changes were located both within the initial resection of the perforated segment or in the subsequent bowel resection in which no acute perforation or ulceration was noted. In most of the affected vessels, there was an accumulation of foamy cells between the endothelium and the muscular media (hematoxylin and eosin stained; original magniﬁcation ⫻ 60). B, Elastin staining of a partially occluded vessel showed an intact elastic lamina with accumulation of pale, foamy cells in the intima (elastin von Gieson stained; original magniﬁcation ⫻ 60). C, Staining for macrophages showed inﬁltration of macrophages through the muscle layer into the intima (anti-CD68; original magniﬁcation ⫻ 60). Immunophenotyping of lymphocytes showed CD3⫹ T cells around the vessel, but not within the vessel (not shown). D, Most of the foam cells stained with antibodies directed against smooth muscle actin, suggesting that they may have a myoﬁbroblastic character (anti–smooth muscle actin; original magniﬁcation ⫻ 60). ing the illness in patients with juvenile DM, and pain that is persistent, progressive, or severe should be carefully evaluated. The absence of occult blood in the stool and normal radiographs do not exclude these potentially serious complications. Close observation and repeated studies are often necessary to reach a diagnosis. Ulceration and perforation should be included in the differential diagnosis of any patient with juvenile DM and abdominal pain. Aggressive management with surgery and multiple immunomodulatory medications appears to have improved the outcome for these severe gastrointestinal manifestations, as many older reports describe a high death rate (4,5). These gastrointestinal ﬁndings may occur later in the course of illness, even when the underlying juvenile DM is improving or only mildly active, and not necessarily when it is severe. In previous reports, gastrointestinal symptoms of abdominal pain, with accompanying vomiting, consti- pation, and hematemesis, occurred an average of 7 months after the onset of juvenile DM, with the majority presenting at less than 6 months from the time of diagnosis (4 – 8). This is in contrast to our patients, who developed this complication at 16 and 25 months after diagnosis. The late presentation of abdominal ﬁndings may be masked by long-term corticosteroids and possibly other therapy. Severe gastrointestinal ulceration and perforation in patients with juvenile DM have been thought to be related to vasculitis (4 –7). Our patients had elevation of von Willebrand factor VIII–related antigen, a laboratory test sometimes used as a measure of juvenile DM disease activity, which suggests endothelial activation (9). The histopathologic manifestations of gastrointestinal tract involvement in juvenile DM have been previously described in patients with untreated or minimally treated disease as a noninﬂammatory acute endarteropathy with arterial and venous 884 intimal hyperplasia and occlusion of vessels by ﬁbrin thrombi in the submucosa, muscularis, and serosal layers (2,3). This is in contrast to our patients, who showed a chronic vasculopathy rather than an acute vasculitis. This chronic vasculopathy is characterized by narrowing or complete occlusion of multiple small and medium arteries, subintimal foam cells, ﬁbromyxoid neointimal expansion, and signiﬁcant luminal compromise and inﬁltration of macrophages through the muscle layers into the intima. This chronic form of noninﬂammatory endarteropathy has occasionally been observed in muscle, skin, and gastrointestinal tract lesions (10). Two recent articles of ulceration and perforation in patients with juvenile DM who received oral and intravenous corticosteroids, along with a number of immunosuppressive agents, report similar histopathologic ﬁndings, with occlusion of arteries and veins, intimal hyperplasia, ﬁbrin thrombi, endothelial proliferation with inﬁltrating lymphocytes and foamy macrophages (5), and ischemic changes (7). It is possible that some of the lesions are a late consequence of the acute noninﬂammatory endarteropathy and are reparative or healed. Chronic vasculopathy has also been described in patients after bone marrow transplantation (11) and solid organ transplantation (12), as well as in animal models of immunosuppression-associated vasculopathy (13). It is characterized by involvement of small muscular arteries with intimal or medial hyperplasia, luminal narrowing, prominent myxoid changes, extravasated red blood cells, and the presence of foamy histiocytes in the intima. Of interest, a number of clinical features of idiopathic inﬂammatory myopathies resemble those of graft versus host disease. Microchimerism, a mechanism that may initiate graft versus host reactions that manifest as autoimmune diseases, is frequently present in the peripheral lymphocytes and affected muscle tissue of patients with juvenile DM (14). Chronic endarteropathy, not acute vasculitis, appears to be underlying the pathogenesis of the ischemic ulceration associated with our patients with late-onset gastrointestinal ulceration and perforation. The chronic endarteropathy, with its delayed onset, may partly be the result of therapy to treat juvenile DM. Longstanding treatment with high doses of corticosteroids could also be a predisposing factor for the development of gastrointestinal complications. The effects of high doses of corticosteroids on the gastrointestinal tract include peptic ulcer disease, upper gastrointestinal bleeding, and perforation (15). One of our patients was also treated with cyclosporine, which was administered for 1 month immediately prior to the development of the gastrointestinal symptoms. The synthesis of endothelins, vasoconstrictor peptides produced by macrophages, can be induced by cyclosporine (16), which may contribute to the development of chronic vasculopathy (13) in both animals and humans. In summary, we described 2 patients with juvenile DM with severe, acute abdominal pain complicated by gastrointestinal ulceration or perforation, along with accompanying histopathology. Chronic endarteropathy, not acute vasculopathy, is associated with the pathology of the ischemic ulceration. The current approach to treatment of Mamyrova et al juvenile DM with immunosuppressive agents may have contributed to delay in the onset of these gastrointestinal manifestations and to their pathologic features. ACKNOWLEDGMENTS We thank Drs. Martha Quezado and Nikolay Nikolov for their critical reading of the manuscript. AUTHOR CONTRIBUTIONS Dr. Rider had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study design. Miller, Rider. Acquisition of data. Mamyrova, Kleiner, James-Newton, Shaham, Rider. Analysis and interpretation of data. Mamyrova, Kleiner, Miller, Rider. Manuscript preparation. Mamyrova, Kleiner, James-Newton, Shaham, Miller, Rider. Figure preparation. Mamyrova, Kleiner, Rider. REFERENCES 1. Laskin BL, Choyke P, Keenan GF, Miller FW, Rider LG. Novel gastrointestinal tract manifestations in juvenile dermatomyositis. J Pediatr 1999;135:371– 4. 2. Crowe WE, Bove KE, Levinson JE, Hilton PK. Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis. Arthritis Rheum 1982;25:126 –39. 3. Banker BQ, Victor M. Dermatomyositis (systemic angiopathy) of childhood. Medicine (Baltimore) 1966;45:261– 89. 4. Downey EC Jr, Woolley MM, Hanson V. Required surgical therapy in the pediatric patient with dermatomyositis. Arch Surg 1988;123:1117–20. 5. Takeda T, Fujisaku A, Jodo S, Koike T, Ishizu A. Fatal vascular occlusion in juvenile dermatomyositis [letter]. Ann Rheum Dis 1998;57:172–3. 6. Magill HL, Hixson SD, Whitington G, Igarashi M, Hannissian A. Duodenal perforation in childhood dermatomyositis. Pediatr Radiol 1984;14:28 –30. 7. Wang IJ, Hsu WM, Shun CT, Chiang BL, Ni YH. Juvenile dermatomyositis complicated with vasculitis and duodenal perforation. J Formos Med Assoc 2001;100:844 – 6. 8. Stefanski JC, Shetty AK. Abdominal pain in a girl with juvenile dermatomyositis. Clin Pediatr 1998;37:561– 4. 9. Bowyer SL, Ragsdale CG, Sullivan DB. Factor VIII related antigen and childhood rheumatic diseases. J Rheumatol 1989; 16:1093–7. 10. Bove K. Neuromuscular diseases. In: Stocker J, Dehner L, editors. Pediatric pathology. Philadelphia: Lippincott; 1992. p. 1181–21. 11. Selby DM, Rudzki JR, Bayever ES, Chandra RS. Vasculopathy of small muscular arteries in pediatric patients after bone marrow transplantation. Hum Pathol 1999;30:734 – 40. 12. Salomon RN, Hughes CC, Schoen FJ, Payne DD, Pober JS, Libby P. Human coronary transplantation-associated arteriosclerosis: evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol 1991;138:791– 8. 13. Chen W, Thoburn CJ, Miura Y, Sommer M, Hruban R, Qian Z, et al. Autoimmune-mediated vasculopathy. Clin Immunol 2001;100:57–70. 14. Reed AM, McNallan K, Wettstein P, Vehe R, Ober C. Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositis? J Immunol 2004;172:5041– 6. 15. Di Fazano CS, Messica O, Quennesson S, Quennesson ER, Inaoui R, Vergne P, et al. Two new cases of glucocorticoidinduced pancreatitis. Rev Rhum Engl Ed 1999;66:235. 16. Jablonski P, Harrison C, Howden B, Rae D, Tavanlis G, Marshall VC, et al. Cyclosporine and the ischemic rat kidney. Transplantation 1986;41:147–51.